Skip to main content

Pyridostigmine in the treatment of orthostatic hypotension

Clinical Autonomic Research volume 15, pages 421–422 (2005)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Castro RRT, Porphirio G, Serra SM, Nobrega ACL (2002) Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary heart disease. Braz J Med Biol Res 35(6):685–689

    PubMed  CAS  Google Scholar 

  2. Cook MR, Graham C, Sastre A, Gerkovich MM (2002) Physological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology 162:186–192

    Article  PubMed  CAS  ISI  Google Scholar 

  3. Douchet MP, Quiring E, Bronner F, Vi-Fane R, Messier M, Chauvin M, Warter JM (1999) Diminution paradoxale des parameters parasympathiques chez les patients myasthéniques. Arch Mal Coeur Vaiss 92:711–717

    PubMed  CAS  Google Scholar 

  4. Iwasaki Y, Wakata N, Kinoshita M (1988) Parkinsonism induced by pyridostigmine. Acta Neurol Scand 78:236

    PubMed  CAS  Article  Google Scholar 

  5. Kelsall HL, Sim MR, Forbes AB, Glass DC, McKenzie DP, Ikin JF, Abramson MJ, Blizzard L, Ittak P (2004) Symptoms and medical conditions in Australian veterans of the 1991 GulfWar: relation to immunisations and other GulfWar exposures. Occup ENvironn Med 61:1006–1013

    CAS  Google Scholar 

  6. Lazartigues E, Freslon JL, Tellioglu T, Brefel-COurbon C, Pelat M, Tran MA, Montastruc JL, Rascol A (1998) Presso rand bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat. Eur J Pharmacol

  7. Levin N, Karussis D, Abramsky O (2003) Parkinson’s disease associated with myasthenia gravis. A report of 4 cases. J Neurol 250:766–767

    PubMed  Google Scholar 

  8. Li L, Gunasekar PG, Borowitz JL, Isom GE (2000) Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis. Neurotoxicology 21:541–552

    PubMed  CAS  ISI  Google Scholar 

  9. Nobrega ACL, dos Resi AF, Moraes RS, Bastos BG, Ferlin EL, Ribeiro JP (2001) Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res 11:11–17

    PubMed  CAS  Google Scholar 

  10. Park KH, Long JP, Cannon JG (1991) Reversal of antihypertensive agent-induced postural hypotension with physostigmine. Arch Int Pharmacodyn 311:155–165

    PubMed  CAS  Google Scholar 

  11. Peden-Adams MM, Dudley AC, EuDaly JG, Allen CT, Gilkenson GS, Keil DE (2004) Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacol Immunotoxicol 26:1–15

    PubMed  CAS  Google Scholar 

  12. Rowsey PJ, Yang YL, Gordon CJ (2002) Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. J Appl Physiol 92:789–794

    CAS  Google Scholar 

  13. Sandroni P, Opfer-Gehrking TL, Singer W, Low PA (2005) Pyridostigmine for treatment of neurogenic orthostatic hypotension: a follow-up survey study. Clin Auton Res 15:51–53

    Article  PubMed  Google Scholar 

  14. Schumm WR, Reppert EJ, Jurich AP, Bollman SR, Webb FJ, Castelo CS, Stever JC, Kaufman M, Deng LY, Krehbiel M, Owens BL, Hall CA, Brown BF, Lash JF, Fink CJ, Crow JR, Bonjour GN (2002) Pyridostigmine bromide and the long term subjective health status of a sample of over 700 male Reserve Component GulfWar era Veterans. Psychol Rep 90:707–721

    PubMed  Google Scholar 

  15. Serra SM, RVC Costa, Bastos BG, Santos KB, Ramalho SHR, Nobrega ACL (2001) Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. Arq Bras Cardiol 76:279–284

    Article  PubMed  CAS  Google Scholar 

  16. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA (2003) Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 74(9):1294–1298

    Article  PubMed  CAS  Google Scholar 

  17. Wacks I, Oster JR, Perez GO, Kett DH (1990) Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis. Am J Kidney Dis 16(1):76–79

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Laboratoire de Pharmacologie Medicale et Clinique, Faculte de Medecine, Toulouse, France

    Jean-Michel Senard

Authors
  1. Jean-Michel Senard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Senard, JM. Pyridostigmine in the treatment of orthostatic hypotension. Clin Auton Res 15, 421–422 (2005). https://doi.org/10.1007/s10286-005-0321-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-005-0321-4

Keywords

  • Public Health
  • Orthostatic Hypotension
  • Pyridostigmine